Lv12
64 积分 2023-12-12 加入
Unravelling the pathogenesis of myasthenia gravis
1天前
已完结
Lambert-Eaton myasthenic syndrome
7天前
已完结
Lambert–Eaton myasthenic syndrome – Diagnosis, pathogenesis and therapy
8天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
11天前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
14天前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
24天前
已完结
Myasthenia gravis: subgroup classification and therapeutic strategies
30天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
1个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
1个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
皖公网安备34019202002308
